CRP and depressive disorder: Other secondary outcomes included quality of life, anthropometric measures (e.g., lean body mass, grip strength, DEXA), pathology (e.g., reactive oxygen species, glutathione peroxidase, superoxide dismutase, pro-inflammatory cytokines and C-reactive protein), physical function, depression and mood scales, measures of peripheral neuropathy and treatment response (e.g., complete remission, partial response, minimal response).